Publication Name	World Journal of Clinical Oncology
Manuscript ID	8313
Country	Mexico

Received	2013-12-25 09:32
Peer-Review Started	2013-12-25 16:43
To Make the First Decision	2014-03-12 17:05
Return for Revision	2014-03-21 20:41
Revised	2014-04-08 08:31
Second Decision	2014-05-29 08:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-29 09:33
Articles in Press	2014-05-29 10:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-24 14:17
Publish the Manuscript Online	2014-12-11 14:23

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Immune therapy for human papillomaviruses-related cancers
Manuscript Source	Invited Manuscript
All Author List	Ricardo Rosales and Carlos Rosales
Funding Agency and Grant Number	Funding Agency Grant Number Virolab, S de RL de CV Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN207514(In part) Consejo Nacional de Ciencia y Tecnología, Mexico 168098
Corresponding Author	Dr. Carlos Rosales Departamento de Inmunología, Instituto de Investigaciones Biomédicas - UNAM, Apdo. Postal 70228, Cd. Universitaria, México D.F. - 04510, MEXICO
Key Words	Human papillomavirus; T cell; Immunoglobulin; Antibody; Vaccinia virus
Core Tip	Infection with human papillomavirus (HPV) is very common and it is associated with benign and malignant proliferation of skin and mucosae. Low-risk HPV produce warts; while high-risk HPV induce tumors. Because there are not antiviral drugs for HPV infection, current therapies involve surgical removal of the lesion. Unfortunately, after surgery many recurrences still appear and about 50% of the HPV-cancer patients die. In the past decade, new therapeutic strategies geared to generate an efficient virus-specific cytotoxic response have been developed. This review describes the current status of the several therapeutic strategies used to treat HPV-induced lesions.
Publish Date	2014-12-11 14:23
Citation	Rosales R, Rosales C. Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol 2014; 5(5): 1002-1019
URL	http://www.wjgnet.com/2218-4333/full/v5/i5/1002.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i5.1002

Full Article (PDF)	WJCO-5-1002.pdf
Full Article (Word)	WJCO-5-1002.doc
Manuscript File	8313-Review.docx
Answering Reviewers	8313-Answering reviewers.pdf
Copyright License Agreement	8313-Copyright assignment.pdf
Peer-review Report	8313-Peer review(s).pdf
Scientific Misconduct Check	8313-CrossCheck.jpg
Scientific Editor Work List	8313-Scientific editor work list.pdf